<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, basing on our data, tricin appears to be an attractive candidate for future clinical study. Tricin has been shown to be safe for clinical development as a cancer chemopreventive agent [
 <xref rid="B42-molecules-25-03730" ref-type="bibr">42</xref>] and be bioavailable when consumed with the diet in mice [
 <xref rid="B43-molecules-25-03730" ref-type="bibr">43</xref>]. Upon the newly confirmed edible source (i.e., medicinal grains) of tricin, the tricin-containing food can be further developed so that the multifunctional nutraceutical values of tricin can be translated into clinical uses and improve CRC patientsâ€™ colon health.
</p>
